Skip to main content
. Author manuscript; available in PMC: 2015 Mar 2.
Published in final edited form as: Am J Cardiol. 2012 Sep 14;110(12):1793–1798. doi: 10.1016/j.amjcard.2012.07.045

Table 4.

Predictors of Diastolic Dysfunction

Stage ≥ 1 (Model R2 = 0.24) Mean e′ (Model R2 = 0.27) Mean E/e′ (Model R2 = 0.14)
β (SE) p β (SE) p β (SE) p
10 year Framingham Risk Score (*) 0.07 (0.04) 0.09 −0.11 (0.04) 0.01 0.02 (0.04) 0.59
Metabolic Syndrome −0.01 (0.46) 0.98 −0.07 (0.54) 0.90 0.59 (0.54) 0.28
Subclinical Coronary Artery Disease −0.11 (0.58) 0.84 −0.36 (0.69) 0.60 −0.03 (0.69) 0.96
Left Ventricular Mass Index 0.009 (0.01) 0.41 0.005 (0.01) 0.70 −0.006 (0.01) 0.63
Epicardial Fat Volume Index 0.03 (0.01) 0.01 −0.02 (0.006) <0.0001 0.04 (0.01) 0.001

Values in table are nonstandardized correlation coefficient (B) with standard error (SE) and p values after adjusting for all the covariates listed.

(*)

Framingham Risk Score included: age, gender, systolic blood pressure, total cholesterol, high density lipoprotein, smoking status. LVMI stands for left ventricular mass index, EFV – epicardial fat volume index.